PSMD5

26S proteasome non-ATPase regulatory subunit 5 is an is_associated_with::enzyme that in humans is encoded by the PSMD5 is_associated_with::gene.

Function
The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a non-ATPase subunit of the 19S regulator base.

Clinical significance
The Proteasome and its subunits are of clinical significance for at least two reasons: (1) a compromised complex assembly or a dysfunctional proteasome can be associated with the underlying pathophysiology of specific diseases, and (2) they can be exploited as drug targets for therapeutic interventions. More recently, more effort has been made to consider the proteasome for the development of novel diagnostic markers and strategies. An improved and comprehensive understanding of the pathophysiology of the proteasome should lead to clinical applications in the future.

The proteasomes form a pivotal component for the Ubiquitin-Proteasome System (UPS) and corresponding cellular Protein Quality Control (PQC). Protein is_associated_with::ubiquitination and subsequent is_associated_with::proteolysis and degradation by the proteasome are important mechanisms in the regulation of the is_associated_with::cell cycle, is_associated_with::cell growth and differentiation, gene transcription, signal transduction and is_associated_with::apoptosis. Subsequently, a compromised proteasome complex assembly and function lead to reduced proteolytic activities and the accumulation of damaged or misfolded protein species. Such protein accumulation may contribute to the pathogenesis and phenotypic characteristics in neurodegenerative diseases, cardiovascular diseases,   inflammatory responses and autoimmune diseases,  and systemic DNA damage responses leading to is_associated_with::malignancies.

Several experimental and clinical studies have indicated that aberrations and deregulations of the UPS contribute to the pathogenesis of several neurodegenerative and myodegenerative disorders, including is_associated_with::Alzheimer's disease, is_associated_with::Parkinson's disease and is_associated_with::Pick's disease, is_associated_with::Amyotrophic lateral sclerosis (is_associated_with::ALS), is_associated_with::Huntington's disease, is_associated_with::Creutzfeldt-Jacob disease, and motor neuron diseases, polyglutamine (PolyQ) diseases, is_associated_with::Muscular dystrophies and several rare forms of neurodegenerative diseases associated with is_associated_with::dementia. As part of the Ubiquitin-Proteasome System (UPS), the proteasome maintains cardiac protein homeostasis and thus plays a significant role in cardiac is_associated_with::Ischemic injury, is_associated_with::ventricular hypertrophy and is_associated_with::Heart failure. Additionally, evidence is accumulating that the UPS plays an essential role in malignant transformation. UPS proteolysis plays a major role in responses of cancer cells to stimulatory signals that are critical for the development of cancer. Accordingly, gene expression by degradation of is_associated_with::transcription factors, such as is_associated_with::p53, is_associated_with::c-Jun, is_associated_with::c-Fos, is_associated_with::NF-κB, is_associated_with::c-Myc, HIF-1α, MATα2, is_associated_with::STAT3, sterol-regulated element-binding proteins and is_associated_with::androgen receptors are all controlled by the UPS and thus involved in the development of various malignancies. Moreover, the UPS regulates the degradation of tumor suppressor gene products such as is_associated_with::adenomatous polyposis coli (APC) in colorectal cancer, is_associated_with::retinoblastoma (Rb). and is_associated_with::von Hippel-Lindau tumor suppressor (VHL), as well as a number of is_associated_with::proto-oncogenes (is_associated_with::Raf, is_associated_with::Myc, Myb, Rel, Src, Mos, Abl).The UPS is also involved in the regulation of inflammatory responses. This activity is usually attributed to the role of proteasomes in the activation of NF-κB which further regulates the expression of pro inflammatory is_associated_with::cytokines such as is_associated_with::TNF-α, IL-β, IL-8, is_associated_with::adhesion molecules (is_associated_with::ICAM-1, is_associated_with::VCAM-1, P selectine) and is_associated_with::prostaglandins and is_associated_with::nitric oxide (NO). Additionally, the UPS also plays a role in inflammatory responses as regulators of leukocyte proliferation, mainly through proteolysis of cyclines and the degradation of CDK inhibitors. Lastly, is_associated_with::autoimmune disease patients with SLE, is_associated_with::Sjogren's syndrome and is_associated_with::rheumatoid arthritis (RA) predominantly exhibit circulating proteasomes which can be applied as clinical biomarkers.

Interactions
PSMD5 has been shown to interact with is_associated_with::PSMC2.